Enlivex Therapeutics For Profit
Allocetra™ is an innovative immunotherapy that is being developed to rebalance life-threatening hyperactivity of the immune system, using the immune system’s own natural regulation mechanisms. By intelligently engaging macrophages and dendritic cells, Allocetra™ is designed to avert cytokine storms and restores safe immune balance – without suppressing the immune system.
Founded Date:
2005-10-01
Headquarters:
Ness Ziona, HaMerkaz, Israel
Technology:
Biomarker panels
Employee Number:
11-50
Industry:
Clinical Data Management
Estimated Revenue:
$1M to $10M
Funding Status:
IPO